name: Microbiology - Specialist/Technologist, Pathology


name: Allopathic & Osteopathic Physicians; Surgery, Surgery of the Hand


name: {4 (0.8 ML adalimumab 50 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen - Psoriasis Starter Pack]


name: {2 (fentanyl 0.6 MG/ACTUAT Mucosal Spray) } Pack


name: {2 (fentanyl 0.6 MG/ACTUAT Mucosal Spray [Subsys]) } Pack [Subsys 1200 MCG]


name: {2 (fentanyl 0.8 MG/ACTUAT Mucosal Spray) } Pack


name: {2 (fentanyl 0.8 MG/ACTUAT Mucosal Spray [Subsys]) } Pack [Subsys 1600 MCG]


name: ICD-10-CM complex map reference set (foundation metadata concept)


name: REFERS TO concept association reference set


name: {4 (0.8 ML adalimumab 50 MG/ML Auto-Injector) } Pack


name: AVOBENZONE 3 g in 100 g / OCTOCRYLENE 5 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL CREAM [Regeneration Wrinkle Control Cream SPF 15]


name: {1 (cariprazine 1.5 MG Oral Capsule) / 6 (cariprazine 3 MG Oral Capsule) } Pack


name: OCTINOXATE 63.1 mg in 1 g / TITANIUM DIOXIDE 31.6 mg in 1 g TOPICAL CREAM [ideal flawless invisible coverage cream to powder foundation]


name: P-PHENYLENEDIAMINE 1.2 mg in 150 g TOPICAL CREAM [Obeo The Mee Plus Hair Color Cream Natural Brown]


name: P-PHENYLENEDIAMINE 2.39 mg in 150 g TOPICAL CREAM [Obeo The Mee Plus Hair Color Cream Dark Brown]


name: BACLOFEN 1 g in 1 g NOT APPLICABLE POWDER


name: CIDOFOVIR ANHYDROUS 1 g in 1 g NOT APPLICABLE POWDER


name: SALICYLIC ACID 0.001 in 150 mL / PANTHENOL 0.001 in 150 mL / MENTHOL 0.001 in 150 mL TRANSDERMAL LIQUID [Cellapy Haircell Meso Tonic]


name: SALICYLIC ACID 0.001 in 300 mL / NIACINAMIDE 0.001 in 300 mL / PANTHENOL 0.001 in 300 mL / MENTHOL 0.001 in 300 mL TOPICAL SHAMPOO [Cellapy Haircell]


name: Azelastine Hydrochloride;Fluticasone Propionate 137 MCG/1 ACTUATION; 0.05 MG/1 ACTUATION Nasal Spray [DERMACINRX AZENASE PAK]


name: Azelastine Hydrochloride;Fluticasone Propionate 137 MCG/1 ACTUATION; 0.05 MG/1 ACTUATION Nasal Spray


name: Capsaicin/Menthol/Methyl Salicylate;Naproxen 0.014%-23%-10%; 500 MG Multiple Routes Kit


name: Chlorhexidine Gluconate/Isopropyl Alcohol;Lidocaine Hydrochloride 2%-70%; 4% Multiple Routes Solution


name: Saf-Clens AF Dermal Wound Cleanser 12OZ 6


name: {1 (cariprazine 1.5 MG Oral Capsule [Vraylar]) / 6 (cariprazine 3 MG Oral Capsule [Vraylar]) } Pack [Vraylar 1.5/3 Mixed Pack]


name: ALLANTOIN 0.3 g in 100 mL TOPICAL LIQUID [Skin Barista Rice Bran Cleansing Foam]


name: chlorhexidine / salicyloyl phytosphingosine


name: Cream, Multi Ingredient Topical application Cream [WILD ROOT HAIR GROOM]


name: Hair Care Preparation Topical application Gel/Jelly [PROTEIN 29 HAIR GROOM]


name: Hair Care Preparation Topical application Liquid [PROTEIN 29 HAIR GROOM]


name: Hair Care Preparation Topical application Liquid [WILD ROOT HAIR GROOM]


name: transparent dressing 2.36" X 2.75" TOPICAL BANDAGE


name: Diclofenac Sodium;Isopropyl Alcohol;Metaxalone 1.5%; 70%; 800 MG Multiple Routes Kit [LORVATUS]


name: Gabapentin;Lidocaine Hydrochloride/Menthol 300 MG; 4%-1% Multiple Routes Kit [SMARTRX GABA KIT]


name: DIMETHICONE 1.5 mg in 30 mL TOPICAL CREAM [Prestige Caviar Essential Barrier Eye Cream]


name: DIMETHICONE 2.6 mg in 130 mL TOPICAL EMULSION [Prestige Caviar Full Moisturizing Emulsion]


name: NIACINAMIDE 2.6 mg in 130 mL / ADENOSINE 0.052 mg in 130 mL TOPICAL LIQUID [Prestige Caviar Full Intensive Vitality Toner]


name: NIACINAMIDE 1 mg in 50 mL / ADENOSINE 0.02 mg in 50 mL TOPICAL CREAM [Prestige Caviar Super Aqua Serum]


name: GLYCERIN 13.7 mg in 50 mL / DIMETHICONE 1 mg in 50 mL TOPICAL CREAM [Prestige Caviar Nourishing Daily Cream]


name: CATHETER,FOLEY SILICONE 10FR 3ML BARD #165810


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 16FR CURE #CS16


name: CATHETER,SELF-CATH 12FR FEMALE COLOPLAST #4212


name: DRESSING,THERABOND 3D 4.25IN X 4.25IN A#3DAC44


name: FREESTYLE PRECISION NEO (GLUCOSE) TEST STRIP


name: Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme


name: Hydrolytic Lysosomal Triacylglycerol-specific Enzyme


name: Titanium Dioxide 50 mg in 1 g / Zinc oxide 60 mg in 1 g TOPICAL LOTION [Essential Defense Mineral Shield Broad Spectrum SPF 32 TINTED Sunscreen]


name: Titanium Dioxide 50 mg in 1 g / Zinc oxide 60 mg in 1 g TOPICAL LOTION [Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen]


name: ZINC OXIDE 120 mg in 1 g / OCTINOXATE 75 mg in 1 g TOPICAL LOTION [Essential Defense Everyday Clear Broad Spectrum SPF 47 Sunscreen]


name: needles, disposable 24 gauge X 1 1/4" MISCELL NEEDLE, DISPOSABLE


name: needles, disposable 32 gauge X 5/16" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 23 gauge X 5/8" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 26 gauge X 1" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 27 gauge X 1" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 30 gauge X 5/16" MISCELL NEEDLE, DISPOSABLE


name: syringe,safety with needle,3 mL 19 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety with needle,3 mL 19 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: Capsaicin;Diclofenac Sodium;Omeprazole 0.025%; 75 MG; 20 MG Multiple Routes Kit


name: CVS Series 100 Upper Arm Blood Pressure Monitor System


name: CVS Series 800 Upper Arm Blood Pressure Monitor System


name: Benzalkonium Chloride;Furosemide 0.0013 GM/1 ML; 20 MG Multiple Routes Kit [DIUSCREEN MULTI-DRUG MEDICATED TEST KIT]


name: cardioplegic solution no.16 26 mEq/1,052.8 mL (potassium) PERFUSION PLASTIC BAG, PERFUSION (ML)


name: formoterol fumarate dihydrate, micronized 100 % MISCELL POWDER (GRAM)


name: Smart Sense Comfort Assist Short Needle 3/10ML 31G 5/16 inch Insulin Syringe


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 8 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [Kroger Sheer dry-touch SFP 30]


name: NIACINAMIDE 0.02 in 30 mL / ADENOSINE 0.0004 in 30 mL TOPICAL CREAM [PRIMEROSE DOUBLE EFFECT EYE]


name: Capsaicin;Diclofenac Sodium 0.025%; 1.5% Multiple Routes Kit


name: Capsaicin/Menthol/Methyl Salicylate;Gabapentin 0.0375%-5%-20%; 300 MG Multiple Routes Kit [SMART RX GABA-V]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 20 g in 100 g TOPICAL GEL [Secret Clinical Strength Clear Clean Lavender]


name: How Often Have Numbness or Tingling in Hands or Feet


name: How Much Distress Numbness or Tingling in Hands or Feet


name: Usual Severity Numbness or Tingling in Hands or Feet


name: Bothered by General Aches and Pains Question


name: How Much Distress I Don't Look Like Myself


name: How Big a Problem is Your Ability to Have an Erection


name: How Much Distress Swelling of Arms or Legs


name: Importance Rating Score 4 (4-Point Importance Scale)


name: Refrain from Smoking After a Meal Question


name: Cardiovascular System Findings Test Code


name: Usual Severity Feeling of I Don't Look Like Myself


name: Intercellular Adhesion Molecule 1 Measurement


name: How Big a Problem is Your Level of Sexual Desire


name: Life Expectancy Greater than Twenty Years


name: How Important Standard Treatment Avoids Side Effects from Treatment


name: How Important Standard Treatment Improves Symptoms


name: How Important Treatment Based on Tumor Molecular Profile Extends Survival


name: How Important Treatment Based on Tumor Molecular Profile Improves Symptoms


name: CDISC SDTM Subject Status Test Code Terminology


name: How Important Standard Treatment Extends Survival


name: Clinical Trial Subject Identification Log


name: CDISC SEND Pregnancy Findings Test Name Terminology


name: CDISC SDTM Subject Status Test Name Terminology


name: Production Assistance for Cellular Therapies


name: How Important Standard Treatment Improves Quality of Life


name: How Important Treatment Based on Tumor Molecular Profile Improves Quality of Life


name: Usual Severity Change in the Way Food Tastes


name: Usual Severity Problems with Sexual Interest or Activity


name: Clinical Trial Roles and Responsibilities Matrix


name: cardiac contractility modulation system (treatment)


name: How Much Distress Difficulty Concentrating


name: Intercellular Adhesion Molecule Measurement


name: How Much Distress Problems with Sexual Interest or Activity


name: How Often Problems with Sexual Interest or Activity


name: How Much Distress Problems with Urination


name: CDISC SDTM Treatment Setting Terminology


name: Preventative Therapy Clinical Trial Setting


name: {30 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 60 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 18]


name: Metastatic Disease Clinical Trial Setting


name: Bothered by Being Easily Distracted Question


name: How Much Distress Change in the Way Food Tastes


name: How True Feel Trusting Right Now Question


name: Problem with Sexual Interest or Activity


name: How Important Treatment Based on Tumor Molecular Profile Avoids Side Effects from Treatment


name: ETHINYL ESTRADIOL 0.03 mg / LEVONORGESTREL 0.15 mg ORAL TABLET [Kurvelo]


name: ASCVD 10-Year Risk Estimator Clinical Classification Question


name: ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification


name: ASSIGN Score Clinical Classification Question


name: Able to Get Medical Care Whenever I Need It


name: Almost Always Have Severe Trouble Breathing


name: Almost Impossible to Get a Decent Night's Sleep


name: Analytic Technique for Assessment of RNAi by Similarity


name: Anti-Phospholipid IgG Antibody Measurement


name: Anti-Phospholipid IgM Antibody Measurement


name: Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification


name: BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation


name: Bothered by Decreased Range of Motion in Arm on Surgery Side


name: Bothered by Difficulty with Bladder Control when Laughing or Crying


name: Bothered by Lumps or Swelling in Certain Parts of My Body


name: Bowel Pattern Causes Considerable Discomfort


name: Bowel Pattern Occasionally Causes Some Discomfort


name: Breast Cancer Prevention Trial Symptom Scales


name: CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV Infection Category


name: CDC Classification System for HIV-Infected Adults and Adolescents Clinical Classification Question


name: CDISC ADaM Subject Trial Status Terminology


name: CDISC Clinical Classification ASSIGN Score Test Code Terminology


name: CDISC Clinical Classification ASSIGN Score Test Name Terminology


name: CDISC Clinical Classification Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Test Code Terminology


name: CDISC Clinical Classification Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Test Name Terminology


name: CDISC Clinical Classification CDC Classification System for HIV-Infected Adults and Adolescents Test Code Terminology


name: CDISC Clinical Classification CDC Classification System for HIV-Infected Adults and Adolescents Test Name Terminology


name: CDISC Clinical Classification CRS-R Test Code Terminology


name: CDISC Clinical Classification CRS-R Test Name Terminology


name: CDISC Clinical Classification FHS CVD 10-Year Risk Score Test Code Terminology


name: CDISC Clinical Classification FHS CVD 10-Year Risk Score Test Name Terminology


name: CDISC Clinical Classification Glasgow Coma Scale-NINDS Version 1.0 Test Code Terminology


name: CDISC Clinical Classification Glasgow Coma Scale-NINDS Version 1.0 Test Name Terminology


name: CDISC Clinical Classification PANSS Test Code Terminology


name: CDISC Clinical Classification PANSS Test Name Terminology


name: CDISC Clinical Classification Reynolds CVD 10-Year Risk Score Test Code Terminology


name: CDISC Clinical Classification Reynolds CVD 10-Year Risk Score Test Name Terminology


name: CDISC Clinical Classification Tanner Scale-Boy Test Code Terminology


name: CDISC Clinical Classification Tanner Scale-Boy Test Name Terminology


name: CDISC Clinical Classification Tanner Scale-Girl Test Code Terminology


name: CDISC Clinical Classification Tanner Scale-Girl Test Name Terminology


name: CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Code Terminology


name: CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Name Terminology


name: CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Children Test Code Terminology


name: CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Children Test Name Terminology


name: CDISC Clinical Classification West Haven Criteria Test Code Terminology


name: CDISC Clinical Classification West Haven Criteria Test Name Terminology


name: CDISC Functional Test TMT Test Code Terminology


name: CDISC Functional Test TMT Test Name Terminology


name: CDISC SDTM Biospecimen Characteristics Test Code Terminology


name: CDISC SDTM Biospecimen Characteristics Test Name Terminology


name: CDISC SDTM Biospecimen Events Dictionary Derived Term Terminology


name: CDISC SDTM Category of Oncology Response Assessment Terminology


name: CDISC SDTM Medical History Event Date Type Terminology


name: CDISC SDTM Schizophrenia Findings About Test Code Terminology


name: CDISC SDTM Schizophrenia Findings About Test Name Terminology


name: CDISC SDTM Subject Status Response Terminology


name: CDISC SDTM Tumor or Lesion Properties Test Result Terminology


name: CDISC SEND Fetal Measurement Test Code Terminology


name: CDISC SEND Fetal Measurement Test Name Terminology


name: CDISC SEND Fetal Pathology Findings Result Category Terminology


name: CDISC SEND Fetal Pathology Findings Result Terminology


name: CDISC SEND Fetal Pathology Findings Test Code Terminology


name: CDISC SEND Fetal Pathology Findings Test Name Terminology


name: CDISC SEND Implantation Findings Result Category Terminology


name: CDISC SEND Implantation Findings Result Terminology


name: CDISC SEND Implantation Findings Test Code Terminology


name: CDISC SEND Implantation Findings Test Name Terminology


name: CDISC SEND Nonclinical DART Sex Terminology


name: CDISC SEND Pregnancy Findings Result Category Terminology


name: CDISC SEND Pregnancy Findings Result Terminology


name: CDISC SEND Pregnancy Findings Test Code Terminology


name: Cannot Plan for the Future Because Cancer is Unpredictable


name: Cardiovascular System Findings Baseline Flag


name: Cardiovascular System Findings Body Position


name: Cardiovascular System Findings Character Result in Standard Format


name: Cardiovascular System Findings Completion Status


name: Cardiovascular System Findings Data Collection Date Time


name: Cardiovascular System Findings Derived Flag


name: Cardiovascular System Findings Elapsed Time


name: Cardiovascular System Findings End Date Time


name: Cardiovascular System Findings Group Identifier


name: Cardiovascular System Findings Numeric Result in Standard Unit


name: Cardiovascular System Findings Original Result Unit


name: Cardiovascular System Findings Planned End of Assessment Interval


name: Cardiovascular System Findings Planned Start of Assessment Interval


name: Cardiovascular System Findings Planned Time Point Name


name: Cardiovascular System Findings Planned Time Point Number


name: Cardiovascular System Findings Reason For Exclusion From Statistics


name: Cardiovascular System Findings Reason Not Done


name: Cardiovascular System Findings Result Standard Unit


name: Cardiovascular System Findings Sequence Number


name: Cardiovascular System Findings Sponsor Defined Identifier


name: Center for Disease Control and Prevention Classification System for HIV-Infected Adults and Adolescents Clinical Classification


name: Change Since Last Time Questionnaire Filled Out


name: Clear About Whether Benefits or Risks are More Important


name: Clear About Which Risks and Side Effects Matter Most


name: Clinical Study Committee Financial Disclosure Form


name: Clinical Trial Committee Member Confidentiality Disclosure Agreement


name: Clinical Trial Coordinating Investigator Documentation


name: Clinical Trial Medical Device Investigators Agreement


name: Clinical Trial Monitoring Visit Follow-up Letter


name: Clinical Trial Ongoing Third Party Oversight Document


name: Clinical Trial Patient Database Change Control


name: Clinical Trial Subject Eligibility Verification Form and Worksheet


name: Clinical Trials Third Party Curriculum Vitae


name: Concern About Your Use of Cocaine or Methamphetamine


name: Concern About Your Use of Sedative or Sleeping Medication


name: Concern About Your Use of an Opioid Medication


name: Confident That I Can Get the Medical Care I Need Without Being Set Back Financially


name: Conflicting Expert Opinions About a Medical Test or Treatment Would Lower My Trust in the Experts


name: Conflicting Expert Opinions About a Medical Test or Treatment Would Make Me Upset


name: Contemplation Ladder Readiness to Quit Smoking Likert Scale


name: Contemplation Ladder for Smoking Cessation


name: Could Not Shake Off the Blues Even with Help from Family


name: Dissatisfied With Some Things About the Medical Care I Receive


name: Doctor Made Final Decision About Which Treatment Will Be Used but Seriously Considered My Opinion


name: Doctor and I Shared Responsibility for Deciding Which Treatment is Best for Me


name: Doctor's Office Has Everything Needed to Provide Complete Medical Care


name: Doctors Sometimes Ignore What I Tell Them


name: Doctors Treat Me In a Very Friendly and Courteous Manner


name: Doctors Usually Spend Plenty of Time With Me


name: Doctors are Careful to Check Everything When Treating and Examining Me


name: Doctors are Good About Explaining the Reasons for Medical Tests


name: Electrocardiogram Planned End of Assessment Interval


name: Electrocardiogram Planned Start of Assessment Interval


name: Electronic Case Report Form Technical Design Document


name: Exclude Cardiovascular System Findings Data From Statistics Indicator


name: Exclude Respiratory System Findings Data From Statistics Indicator


name: Exposure Date Time of Reference Timepoint


name: FHS CVD 10-Year Risk Score Clinical Classification Question


name: Fear of Cancer Getting Worse Gets in Way of Enjoying Life


name: Feel Isolated from Others Because of My Illness or Treatment


name: Felt Numb When Thinking about Prostate Cancer


name: Find it Hard to Get an Appointment for Medical Care Right Away


name: Formalin-Fixed Paraffin-Embedded B-Cell (CD20) Digital Image


name: Formalin-Fixed Paraffin-Embedded B-Cell (CD20) Slide


name: Formalin-Fixed Paraffin-Embedded T-Cell (CD3) Digital Image


name: Formalin-Fixed Paraffin-Embedded T-Cell (CD3) Slide


name: Four of Five Patients Are Able to Have Erections Firm Enough to Have Sexual Intercourse After External Radiation Therapy for Prostate Cancer


name: Four of Five Patients Are Able to Have Erections Firm Enough to Have Sexual Intercourse After Radiation Seeds for Prostate Cancer


name: Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification


name: Frequency Medication Use For the Feeling, To Get High, More Often, or in Larger Doses than Prescribed


name: Geopolitical Entities, Names, and Codes Terminology


name: Global Rating of Change in Joint Pain and Stiffness Questionnaire


name: Gravid Uterus Adjusted Maternal Body Weight


name: Had More Trouble Falling Asleep Because of Thoughts of Prostate Cancer


name: Had Trouble Keeping My Mind on What I was Doing


name: Have Been so Concerned about PSA Test Result Have Thought about Having Test Repeated at Another Lab


name: Have Been so Worried about PSA Test Result Have Thought about Asking Doctor To Repeat It


name: Have Difficulty Getting to Sleep and Staying Asleep


name: Have Easy Access to the Medical Specialists I Need


name: Have Enough Support From Others to Make a Choice


name: Have Feelings about Prostate Cancer but Don't Want to Deal with Them


name: Have Good Range of Movement in My Arm or Leg


name: Have Normal Appetite and Enjoy Good Food


name: Have Periods When Quite Tired or Fatigued


name: Have Periods When Rather Tired or Fatigued


name: Have Some Doubts About the Ability of the Doctors Who Treat Me


name: Have to Limit Physical Activity Because of Condition


name: Have to Limit Social Activity Because of Condition


name: Have to Pay More of My Medical Care Than I Can Afford


name: Healthcare Encounters Data Collection Date Time


name: Healthcare Encounters Dictionary-derived Term


name: Healthcare Encounters End Relative to Reference Time Point


name: Healthcare Encounters Reference End Time Point End


name: Healthcare Encounters Reference Identifier


name: Healthcare Encounters Sponsor Defined Identifier


name: Healthcare Encounters Start Relative to Reference Timepoint


name: Healthcare Encounters Verbatim Description


name: Hearing the Words Prostate Cancer Scared Me


name: How Big a Problem is Abdominal, Pelvic, or Rectal Pain


name: How Big a Problem is Bleeding with Urination


name: How Big a Problem is Breast Tenderness or Enlargement


name: How Big a Problem is Dripping or Leaking Urine


name: How Big a Problem is Increased Frequency of Bowel Movements


name: How Big a Problem is Losing Control of Stools


name: How Big a Problem is Pain or Burning on Urination


name: How Big a Problem is Urgency to Have Bowel Movement


name: How Big a Problem is Waking Up to Urinate


name: How Big a Problem is Watery Bowel Movements


name: How Big a Problem is Weak Urine Stream or Incomplete Emptying


name: How Big a Problem is Your Ability to Reach an Orgasm


name: How Big a Problem is Your Change in Body Weight


name: How Big a Problem is the Need to Urinate Frequently During the Day


name: How Long Do You Expect to Live After Treatment for Prostate Cancer


name: How Long Do You Expect to Live Without Any Treatment for Prostate Cancer


name: How Many Bowel Movements on a Typical Day


name: How Many Pads or Adult Diapers per Day Did You Use to Control Leakage


name: How Much Change in Weight Have You Experienced


name: How Often Awakened in the Morning or Night with an Erection


name: How Often Have You Had Pain or Burning with Urination


name: How Often Have Your Bowel Movements Been Painful


name: How Often had Crampy Pain in Abdomen, Pelvis, or Rectum


name: How Often had Stools That Were Loose or Liquid


name: How Often had Uncontrolled Leakage of Stool or Feces


name: How True Feel Uncertain About Things Right Now


name: In Almost Constant Discomfort Because of Bowel Pattern


name: In Some Degree of Pain Almost Constantly


name: Independent Review Committee Member Curriculum Vitae


name: Investigational Product Device Maintenance Log


name: Investigational Product Retest and Expiry Document


name: Isolate Myself from Others Because of Condition


name: JFK Coma Recovery Scale-Revised Clinical Classification


name: Know the Risks and Side Effects of Each Option


name: Knowledge, Understanding and Judgment Scale


name: Left All Decisions Regarding My Treatment to My Doctor


name: Locally Advanced Disease Clinical Trial Setting


name: Made Final Selection About Which Treatment I Will Receive


name: Made Final Selection of My Treatment After Seriously Considering Doctor's Opinion


name: Medical Care I Have Been Receiving is Just About Perfect


name: Medical Device Report of Prior Investigations


name: Memorial Symptom Assessment Scale - Short Form


name: Modified 18-Item Memorial Anxiety Scale for Prostate Cancer


name: More Anxious About Having Prostate Cancer When Thinking about Having a PSA Test


name: More Anxious about Having Prostate Cancer Whenever Hearing about Friend or Public Figure with Prostate Cancer


name: More Nervous Since Prostate Cancer Diagnosis


name: More Than Half of Patients Will Have Sexual or Urinary Symptoms Within Five Years Without Treatment for Prostate Cancer


name: Most Common Complication After Radiotherapy for Prostate Cancer


name: Most Common Complication After Surgery for Prostate Cancer


name: Most Common Complication Without Treatment for Prostate Cancer


name: Mycobacterium tuberculosis IgA Antibody Measurement


name: Mycobacterium tuberculosis IgE Antibody Measurement


name: Mycobacterium tuberculosis IgG Antibody Measurement


name: Neoadjuvant Therapy Clinical Trial Setting


name: Not Afraid of Trying a Medical Test or Treatment Even If Experts Had Conflicting Opinions


name: Not Often Concerned that Appearance is Worsening


name: Not Worried or Frightened About the Future


name: Occasionally Concerned about Worsening of Physical Appearance


name: Occasionally Have Considerable Trouble Concentrating


name: Occasionally Have Trouble Getting to Sleep and Staying Asleep


name: Often Cough and Have Occasionally Severe Coughing Spells


name: Often Have Persistent and Severe Coughing Spells


name: On Occasion Drink More Than 4 Standard Drinks of Alcohol


name: On Occasion Drink More Than 5 Standard Drinks of Alcohol


name: One Thing to Improve Experience Participating in Research Study


name: One of Ten Patients Will Need Diapers Due to Very Poor Urine Control After Surgery for Prostate Cancer


name: One of Three Patients Will Die Within Ten Years Due to Prostate Cancer Without Treatment


name: One of Three Patients Will Have Urine Control Problem After Surgery for Prostate Cancer


name: One of Three Patients Will Need Diapers Due to Very Poor Urine Control After Surgery for Prostate Cancer


name: Other Things Made Me Think about Prostate Cancer


name: Overall Experience Participating in Research Study


name: Overall How Big a Problem Have Your Bowel Habits Been


name: Overall How Big a Problem is Urinary Function


name: Overall How Big a Problem is Your Sexual Function or Lack of Sexual Function


name: Overall Quality of Life Change by Participating in Research Study


name: Overall Satisfaction with Treatment Received for Prostate Cancer


name: Overall Value Treatment Based on Tumor Molecular Profile


name: PANSS - Passive or Apathetic Social Withdrawal


name: Past Seven Days Frequency of Loss of Control of Bowel Movements


name: Past Seven Days Loss of Control of Bowel Movements Interferes with Usual or Daily Activities


name: Patient Satisfaction Questionnaire Short Form


name: Percent Predicted Inspiratory Vital Capacity


name: Pharmacokinetic Concentration Upper Limit Value


name: Pharmacokinetic Parameters Planned End of Assessment Interval


name: Pharmacokinetic Parameters Planned Start of Assessment Interval


name: Positive and Negative Syndrome Scale Clinical Classification


name: Prefer My Doctor Makes Final Decision About Which Treatment is Used but Seriously Considers My Opinion


name: Prefer My Doctor and I Share Responsibility for Deciding Which Treatment is Best


name: Prefer to Leave All Decisions Regarding Treatment to My Doctor


name: Prefer to Make Final Selection About Which Treatment I Will Receive


name: Prefer to Make Final Selection of My Treatment After Seriously Considering My Doctor's Opinion


name: Preference for Decision About Choosing a Treatment


name: Prostate Cancer Will Spread in One of Three Patients Within Ten Years Without Treatment


name: Recommend Participating in Research Study to Others


name: Refrain from Smoking When Having Coffee or Tea


name: Refrain from Smoking when Celebrating Something


name: Refrain from Smoking when Drinking Alcohol


name: Refrain from Smoking when Feeling the Urge to Smoke


name: Refrain from Smoking when Having a Drink with Friends


name: Refrain from Smoking when Thinking about a Difficult Problem


name: Refrain from Smoking when with Other Smokers


name: Respiratory System Findings Baseline Flag


name: Respiratory System Findings Body Position


name: Respiratory System Findings Character Result in Standard Format


name: Respiratory System Findings Completion Status


name: Respiratory System Findings Data Collection Date Time


name: Respiratory System Findings Date Time of Reference Timepoint


name: Respiratory System Findings Derived Flag


name: Respiratory System Findings Elapsed Time


name: Respiratory System Findings End Date Time


name: Respiratory System Findings Group Identifier


name: Respiratory System Findings Numeric Result in Standard Unit


name: Respiratory System Findings Original Result Unit


name: Respiratory System Findings Planned End of Assessment Interval


name: Respiratory System Findings Planned Start of Assessment Interval


name: Respiratory System Findings Planned Time Point Name


name: Respiratory System Findings Planned Time Point Number


name: Respiratory System Findings Reason For Exclusion From Statistics


name: Respiratory System Findings Reason Not Done


name: Respiratory System Findings Result Standard Unit


name: Respiratory System Findings Sequence Number


name: Respiratory System Findings Sponsor Defined Identifier


name: Respiratory System Findings Time Point Reference


name: Response Evaluation Criteria in Solid Tumors Version 1.0


name: Response Evaluation Criteria in Solid Tumors Version 1.1


name: Reynolds CVD 10-Year Risk Score Clinical Classification Question


name: Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification


name: SEND Developmental and Reproductive Toxicology Implementation Guide Version 1.0


name: Slightly Worried but Not Frightened About Things


name: Sometimes Doctors Make Me Wonder if Their Diagnosis is Correct


name: Strong Desire to Use Marijuana at Least Once a Week


name: Strong Desire to Use Sedative or Sleeping Medication at Least Once a Week


name: Study Day of Cardiovascular System Findings


name: Study Day of Respiratory System Findings


name: Swelling Keeps Me From Wearing What I Want to Wear


name: Swelling Keeps Me from Doing Things I Want to Do


name: Tanner Scale-Boy Clinical Classification Question


name: Those Providing Medical Care Sometimes Hurry Too Much When They Treat Me


name: Thought about Prostate Cancer Even Though Didn't Mean To


name: Three of Four Patients Will Have Penile Erections Firm Enough to Have Sexual Intercourse After Surgery for Prostate Cancer


name: Treatment Decisions Should be Made Within Six Months or Prostate Cancer Can Spread Beyond Cure


name: Tried and Failed to Control, Cut Down, or Stop Drinking


name: Tried and Failed to Control, Cut Down, or Stop Using Heroin


name: Tried and Failed to Control, Cut Down, or Stop Using an Opioid Medication


name: Use Cocaine or Methamphetamine at Least Once a Week


name: Use Sedative or Sleeping Medication Not as Prescribed or Without a Prescription


name: Use of Stimulant Medication Not as Prescribed or Without a Prescription


name: Usually Have Considerable Trouble Concentrating


name: Usually Smoke More Than 10 Cigarettes Each Day


name: Usually Smoke Within 30 Minutes After Waking


name: Usually in Considerable Discomfort Because of Bowel Pattern


name: Very Worried and Frightened About Things


name: WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO Clinical Stage of HIV/AIDS


name: WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification Question


name: WHO Clinical Staging of HIV/AIDS for Children Clinical Classification Question


name: Wait for Emergency Treatment is Too Long Where I Get Medical Care


name: West Haven Criteria Clinical Classification Question


name: Willing to Try Medical Test or Treatment if Experts Had Conflicting Opinions


name: World Health Organization Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification


name: World Health Organization Clinical Staging of HIV/AIDS for Children Clinical Classification


name: Worry About Appearance of Surgical Scars


name: Worsening of Physical Appearance is Constant Preoccupying Concern


name: Worthwhile to Participate in Research Study


name: Would Avoid Making Decisions About A Medical Test or Treatment if Experts Had Conflicting Opinions


name: Would Not Have Confidence in a Medical Test or Treatment if Experts Had Conflicting Opinions


name: Would Participate in Research Study Again


name: You and Your Doctor's Cancer Treatment Decision


name: Reference to Prostate Cancer Brought Up Strong Feelings


name: Cardiovascular System Findings Date Time of Reference Timepoint


name: Cardiovascular System Findings Time Point Reference


name: Use Opioid-Containing Medication Not as Prescribed or Without a Prescription


name: Bothered by Difficulty with Bladder Control at Other Times


name: Doctors Act Too Businesslike and Impersonal Toward Me


name: Frequently Have Trouble Getting to Sleep


name: Have Been so Anxious about PSA Test Have Thought About Delaying It


name: Afraid That Results from PSA Test Would Show That Disease was Getting Worse


name: Most of the Time Concerned that Physical Appearance is Worsening


name: CDISC SEND Nonclinical DART Trial Phases Terminology


name: Occasionally or a Moderate Amount of Time


name: WHO Clinical Staging of HIV/AIDS for Children - WHO Clinical Stage of HIV/AIDS


name: Have Nausea Am as Sick as I Could Possibly Be


name: Tanner Scale-Girl Clinical Classification Question


name: Product quality, supply, distribution, manufacturing and quality system issues


name: Counterfeit, falsified and substandard products


name: Manufacturing facilities and equipment issues


name: Cardiac contractility modulation therapy


name: Transcranial electrical motor evoked potential monitoring


name: Device monitoring procedure not performed


name: Radiofrequency ablation of the cavotricuspid isthmus


name: Pulmonary arterial hypertension WHO functional class III


name: Pulmonary arterial hypertension WHO functional class IV


name: Pulmonary hypertension WHO functional class I


name: Pulmonary hypertension WHO functional class II


name: Pulmonary hypertension WHO functional class III


name: Pulmonary hypertension WHO functional class IV


name: Pulmonary arterial hypertension WHO functional class I


name: Pulmonary arterial hypertension WHO functional class II


name: Cardiac resynchronisation therapy / implantable cardioverter defibrillator replacement


name: Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ)


name: Dual Eligibility Medicare/Medicaid Organization


name: Commercial Managed Care - Pharmacy Benefit Manager


name: Unavailable / No Payer Specified / Blank


name: UltiCare 3/10ML 31G 1/4 inch Insulin Syringe


name: UltiCare 1ML 31G 1/4 inch Insulin Syringe


name: UltiCare 1/2ML 31G 1/4 inch Insulin Syringe


name: Humana True Metrix AIR Blood Glucose Meter Kit


name: HEB inContol Unifine Pentips Plus 32G 5/32 inch Pen Needle


name: eRapid with eBase Controller Nebulizer System


name: Multivitamin with Minerals Hi-Potency Softgel


name: omega-3 polyunsaturated fatty acids 1000 mg oral kit


name: Octinoxate/Zinc Oxide 2.8%-11% Topical application Cream


name: DIMETHICONE 3.36 mg in 1 mL / GLYCERIN 10 mg in 1 mL TOPICAL CREAM [Luxury Revitalizing Nourishing Cream]


name: MENTHOL 0.9 g in 100 g TOPICAL STICK [MEDICATED LIP BALM]


name: GLYCERIN 15 mg in 1 mL / DIMETHICONE 0.13 mg in 1 mL TOPICAL CREAM [Luxury Revitalizing Serum]


name: SESAME SEED 1.2 g in 10 g TOPICAL POWDER [Pibubab gold Grain Pack]


name: POTASSIUM CARBONATE 0.001 in 450 mL TOPICAL LIQUID [Greenfish, Cleaning-S]


name: Zinc Gluconate 50 mg ORAL CAPSULE [Pegasus Male Sexual Enhancer]


name: Zinc Gluconate 50 mg ORAL CAPSULE [Libi Xplode Male Sexual Enhancer]


name: Zinc Gluconate 50 mg ORAL CAPSULE [Blue Monster Male Sexual Enhancer]


name: AVOBENZONE 2.1 g in 100 mL / OCTOCRYLENE 5.4 g in 100 mL / OCTINOXATE 5 g in 100 mL TOPICAL LOTION [KLENSKIN BROAD SPECTRUM SPF-50]


name: GLYCERIN 5 mg in 1 mL / DIMETHICONE 4.2 mg in 1 mL TOPICAL CREAM [Luxury Revitalizing Moisturizing Cream]


name: TITANIUM DIOXIDE 2.53 g in 100 g / ZINC OXIDE 11.9 g in 100 g TOPICAL LOTION [Renewal Firming Day Broad Spectrum SPF 30]


name: {14 (venetoclax 10 MG Oral Tablet [Venclexta]) / 21 (venetoclax 100 MG Oral Tablet [Venclexta]) / 7 (venetoclax 50 MG Oral Tablet [Venclexta]) } Pack [Venclexta Starting Pack]


name: AVOBENZONE 2.0 g in 100 g / HOMOSALATE 5.5 g in 100 g / OCTOCRYLENE 4.0 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [CVS Sheer SFP 30]


name: Diclofenac Sodium;Isopropyl Alcohol 1.5%; 70% Topical application Kit [VOPAC MDS]


name: OCTISALATE 5 g in 100 g / OCTOCRYLENE 3 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL STICK [Vitamin E SPF15 Lip Balm]


name: OCTINOXATE 30 mg in 1 mL TOPICAL CREAM [Teint Miracle Octinoxate Sunscreen Broad Spectrum SPF 15]


name: OCTINOXATE 3.4 mg in 50 mL / HOMOSALATE 3 mg in 50 mL / OCTISALATE 2.25 mg in 50 mL / OCTOCRYLENE 1.25 mg in 50 mL / TITANIUM DIOXIDE 0.7 mg in 50 mL TOPICAL CREAM [Sun Project Water Sun Cream SPF50]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL CREAM [Absolue Premium Bx Sunscreen Broad Spectrum SPF 15 Absolute Replenishing]


name: WITCH HAZEL 0.02 g in 27 g TOPICAL PATCH [Haishen 80 Sea Cucumber Nutritive Fresh Mask]


name: Menthol 0.003 in 500 g / Salicylic Acid 0.0025 in 500 g / Dexpanthenol 0.002 in 500 g TOPICAL SHAMPOO [HASOL Anagen Scalp]


name: Dexpanthenol 0.002 in 100 mL / Menthol 0.003 in 100 mL / Salicylic Acid 0.0025 in 100 mL TOPICAL LIQUID [HASOL Anagen Hair Tonic]


name: DIMETHICONE 0.8 g in 80 g TOPICAL CREAM [Haishen 80 Sea Cucumber Nutritive Fresh]


name: Witch Hazel 0.03 g in 30 mL TOPICAL PATCH [Freeze 24 7 Intense Hydrating Face Mask]


name: Witch Hazel 0.03 g in 30 mL TOPICAL PATCH [Freeze 24 7 Anti Gravity Lifting Face Mask]


name: Witch Hazel 0.03 g in 30 mL TOPICAL PATCH [FREEZE 24 7 RADIANCE BRIGHTENING FACE MASK]


name: Dimethicone 1.05 g in 50 mL TOPICAL GEL [MELA DEFENSE WHITE ESSENCE]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL LOTION [Meijer Sport SPF 30]


name: OCTOCRYLENE 4 g in 100 g / ZINC OXIDE 5 g in 100 g TOPICAL LOTION [Meijer Zinc SPF 50]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [meijer Baby Tear Free SPF 50 CS]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Meijer Kids Tear Free SPF 50]


name: Capsaicin/Menthol;Celecoxib 0.0375%-5%; 200 MG Multiple Routes Kit [SMARTRX CAPXIB KIT]


name: OCTOCRYLENE 4 g in 100 g / ZINC OXIDE 5 g in 100 g TOPICAL LOTION [Walgreens Zinc SPF 50]


name: OCTOCRYLENE 4 g in 100 g / ZINC OXIDE 5 g in 100 g TOPICAL LOTION [Rite Aid Zinc SPF 50]


name: ZINC OXIDE 66 mg in 1 mL TOPICAL LOTION [Daily Face Broad Spectrum]


name: ZINC OXIDE 100 mg in 1 mL TOPICAL GEL [Dr. Perrys Day Thyme SPF 20 Broad Spectrum Sunscreen]


name: OMEPRAZOLE 0.99 kg in 1 kg NOT APPLICABLE POWDER


name: HYDROCORTISONE SODIUM SUCCINATE 0.98 kg in 1 kg NOT APPLICABLE POWDER


name: OCTINOXATE 2.25 g in 30 mL / OXYBENZONE 0.9 g in 30 mL TOPICAL CREAM [Marcelle CC Cream Complete Correction Sunscreen Broad Spectrum SPF 35]


name: gabapentin/lidocaine HCl/menthol 300 mg-4 %-1 % MISCELL KIT, GEL AND CAPSULE


name: sapropterin dihydrochloride 100 % MISCELL POWDER (GRAM)


name: needles, disposable 18 gauge X 1 1/4" MISCELL NEEDLE, DISPOSABLE


name: methyl aminolevulinate HCl 100 % MISCELL POWDER (GRAM)


name: fluocinolone acetonide, micronized 100 % MISCELL POWDER (GRAM)


name: enteral pump accessory for fat hydrolysis MISCELL CARTRIDGE (EA)


name: {14 (venetoclax 10 MG Oral Tablet) / 21 (venetoclax 100 MG Oral Tablet) / 7 (venetoclax 50 MG Oral Tablet) } Pack


name: lidocaine / mineral oil / petrolatum / phenylephrine


name: TRACHEOSTOMY TUBE HOLDER,2-PIECE MARPAC #201


name: TRACHEAL SUCTION SET 14FR BALLARD #22012356


name: SUCTION TUBE ATTACHMENT DEVICE SAGE #6429


name: DRESSING,RELIAMED FOAM 6IN X 6IN #ZDF66B


name: DRESSING,CALCICARE CALCIUM ALGINATE 1IN X 18IN H#529940R


name: DRESSING,AQUACEL HYDROFIBER 0.39IN X 18IN C#420127


name: DRESSING,ALGISITE M CALCIUM ALGINATE 3/4IN X 12IN #59480400


name: CATHETER,SELF-CATH CLOSED SYSTEM 14FR COLOPLAST #3114


name: CATHETER,INTERMITTENT,MAGIC3 FEMALE 12FR ROCHESTER #51612


name: CATHETER,FOLEY SILICONE 2-WAY 18FR 5ML RUSCH #170605180


name: CATHERIZATION SET,FOLEY 15FR BARD #772414


name: ACKR1, -67T-C, PROMOTER (dbSNP rs2814778)


name: SOX9, 136-KB DEL, UPSTREAM REGULATORY REGION


name: SOX9, 577-KB DEL, UPSTREAM REGULATORY REGION


name: SOX9, 240-KB DEL, UPSTREAM REGULATORY REGION


name: SOX9, 148-KB DUP, UPSTREAM REGULATORY REGION


name: SOX9, 96-KB TRIPLICATION, UPSTREAM REGULATORY REGION


name: RPGRIP1, 1-BP DEL, 1007A (dbSNP rs61751266)


name: DMPK, (CTG)n REPEAT EXPANSION, 3-PRIME UTR


name: PARN, 1-BP DUP, 863A (dbSNP SCV000206799)


name: PARN, IVS13DS, G-T, +1 (dbSNP SCV000206798)


name: TBX6, HAPLOTYPE, T-C-A (dbSNP rs2289292, dbSNP rs3809624, dbSNP rs3809627)


name: SIGMAR1, +31A-G, 3-PRIME UTR (dbSNP rs4879809)


name: MMP19, 6-KB TRIPLICATION, UPSTREAM REGULATORY REGION


name: MOGS, ALA22GLU (dbSNP rs753961807) AND ARG110HIS


name: ITPA, IVS2DS, A-C, +21 (dbSNP rs7270101)


name: activation of maternal process involved in parturition


name: inhibition of maternal process involved in parturition


name: regulation of antigen processing, endogenous antigen via MHC class I


name: activation of transformation of host cell by virus


name: inhibition of transformation of host cell by virus


name: response to the introduction of novel objects


name: stress-activated AMP-activated protein kinase signaling cascade


name: ligand-gated ion channel signaling pathway


name: regulation of vascular associated smooth muscle cell membrane depolarization


name: endocannabinoid signaling pathway involved in trans-synaptic signaling


name: positive regulation of maternal process involved in parturition


name: negative regulation of maternal process involved in parturition


name: positive regulation of wax biosynthetic process


name: regulation of basement membrane assembly involved in embryonic body morphogenesis


name: positive regulation of transformation of host cell by virus


name: negative regulation of transformation of host cell by virus


name: regulation of adipose tissue development


name: positive regulation of convergent extension involved in somitogenesis


name: regulation of action potential firing threshold


name: regulation of action potential firing rate


name: chemical synaptic transmission, postsynaptic


name: presynaptic process involved in chemical synaptic transmission


name: postsynapse to nucleus signaling pathway


name: cell surface receptor signaling pathway via STAT


name: acetylcholine receptor signaling pathway


name: negative regulation of lung blood pressure


name: 6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-)


name: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)


name: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), 2015


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Capsule) / 4 (ferrous fumarate 75 MG Oral Capsule) } Pack


name: needles, disposable 31 gauge X 5/16" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 28 gauge X 1/2" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 29 gauge X 1/2" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 31 gauge X 5/16" MISCELL NEEDLE, DISPOSABLE


name: syringe with needle, insulin, safety, 1 mL 31 gauge X 5/16" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety with needle,1 mL 26 gauge X 5/8" MISCELL SYRINGE, EMPTY DISPOSABLE


name: Octinoxate 0.068 g in 1 g TOPICAL LIPSTICK [Esika PRO HD COLOR MATTE HIGH DEFINITION COLOR SPF 20 FUCSIA GALA MATE - PURPLE]


name: Dimethicone 0.15 g in 15 mL TOPICAL CREAM [Bling Magic Speedy Brightening Moisturizer]


name: HYALURONATE SODIUM 3.5 mg in 1 mL TOPICAL GEL [Hyaluronic Acid Gel]


name: Homosalate 40 mg in 1 mL / Octinoxate 35 mg in 1 mL / Avobenzone 30 mg in 1 mL / Octocrylene 27.9 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day S1 Broad Spectrum SPF 25]


name: Homosalate 40 mg in 1 mL / Octinoxate 35 mg in 1 mL / Avobenzone 30 mg in 1 mL / Octocrylene 27.9 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day T1 Broad Spectrum SPF 25]


name: Homosalate 80 mg in 1 mL / Octisalate 40 mg in 1 mL / Avobenzone 30 mg in 1 mL / Octocrylene 20 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day S3 Broad Spectrum SPF 25]


name: Homosalate 80 mg in 1 mL / Octisalate 40 mg in 1 mL / Avobenzone 30 mg in 1 mL / Octocrylene 20 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day T3 Broad Spectrum SPF 25]


name: Octinoxate 40 mg in 1 mL / Avobenzone 23 mg in 1 mL / Octocrylene 20 mg in 1 mL / Homosalate 20 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day S9 Broad Spectrum SPF 25]


name: Octinoxate 40 mg in 1 mL / Avobenzone 23 mg in 1 mL / Octocrylene 20 mg in 1 mL / Homosalate 20 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day T9 Broad Spectrum SPF 25]


name: Titanium Dioxide 34 mg in 1 mL / Zinc Oxide 33.9 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day S2 Broad Spectrum SPF 20]


name: Titanium Dioxide 34 mg in 1 mL / Zinc Oxide 33.9 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day T2 Broad Spectrum SPF 20]


name: ZINC OXIDE 35 mg in 1 g TOPICAL STICK [Rosehip and Lemongrass Lip SPF 15]


name: AVOBENZONE 2 g in 100 mL / OCTOCRYLENE 6 g in 100 mL / OCTISALATE 3 g in 100 mL TOPICAL LOTION [PICTURE PERFECT DAY DAILY MOISTURIZER]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-4%-4%-2% Topical application Lotion [AVEENO ABSOLUTELY AGELESS W/SPF30]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-4%-4%-2% Topical application Lotion


name: Dimethicone/Titanium Dioxide/Zinc Oxide 1.2%-1.5%-15% Topical application Cream


name: CARBAMIDE PEROXIDE 8.3 g in 100 mL DENTAL GEL, DENTIFRICE [Lutooth Tooth Whitening Kit]


name: ZINC OXIDE 227.5 mg in 1 g TOPICAL CREAM [Raw Elements Lip Rescue 30 Broad Spectrum SPF 30]


name: ZINC OXIDE 227.5 mg in 1 g TOPICAL STICK [Raw Elements Eco 30 Broad Spectrum SPF 30]


name: ZINC OXIDE 230 mg in 1 mL TOPICAL CREAM [Raw Elements Eco Formula 30 Broad Spectrum SPF 30]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 7.5 g in 100 g / OXYBENZONE 2.5 g in 100 g TOPICAL STICK [Blistex Deep Renewal International]


name: syringe with needle,disposable,insulin 1 mL 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin,0.3 mL 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin,0.5 mL 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: BAG,URINARY DRAINAGE 2000ML COVIDIEN #3512V


name: BRIEF,TRANQUILITY AIR PLUS XXXX-LARGE #2195


name: CATHETER,EXTERNAL X-LARGE KIT UROCARE #521140


name: CATHETER,INTERMITTENT APOGEE 14FR H#11426


name: CATHETER,INTERMITTENT APOGEE 14FR H#91426


name: CATHETER,INTERMITTENT VAPRO PLUS 14FR H #71144


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 12FR CURE #CS12


name: CATHETER,INTERMITTENT,MAGIC3 10FR ROCHESTER #53310


name: CATHETER,SPEEDICATH COMPACT COLOPLAST #28702


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1401


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1402


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1403


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1404


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1405


name: SUCTION SET,SUCTION PRO 72 14FR CLOSED CATHETER #Z120N-14


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND52130


name: SUCTION TUBE ATTACHMENT DEVICE SAGE #6629


name: TRANSPARENT DRESSING W/BORDER 4IN X 4.5IN


name: PAD,FOAM 0.25IN X 18IN X 72IN BIACARE #5301


name: PAD,FOAM 0.5IN X 18IN X 72IN BIACARE #5302


name: Glycerin 0.5 g in 2 g TOPICAL GEL [Double S Essence Clean 2g 5ea]


name: Glycerin 3.75 g in 15 g TOPICAL GEL [Double S Essence Clean]


name: Lidocaine/Prilocaine 2.5%-2.5% Topical application Cream [VENIPUNCTURE CPI]


name: syringe with needle,insulin 0.3 mL (half unit mark) 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 4 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 2.6 g in 100 mL TOPICAL LOTION [Olay Age Defying Anti-Wrinkle Day Broad Spectrum SPF 15]


name: OCTISALATE 3 g in 100 mL / ZINC OXIDE 6.82 g in 100 mL TOPICAL CREAM [Sable Long Wear Makeup Broad Spectrum SPF 20]


name: OCTISALATE 3 g in 100 mL / ZINC OXIDE 6.82 g in 100 mL TOPICAL CREAM [Caramel Long Wear Makeup Broad Spectrum SPF 20]


name: GLYCERIN 1.98 mg in 1 mL TOPICAL CREAM [Renovating Regenerating Nourishing Cream]


name: OCTISALATE 3 g in 100 mL / ZINC OXIDE 6.82 g in 100 mL TOPICAL CREAM [Earth Long Wear Makeup Broad Spectrum SPF 20]


name: GLYCERIN 0.25 mg in 1 mL TOPICAL CREAM [Renovating Regenerating Serum]


name: GLYCERIN 7.8 mg in 1 mL TOPICAL CREAM [Renovating Regenerating Moisturizing Cream]


name: ZINC OXIDE 9.45 mg in 1 mL TOPICAL CREAM [Light Beam Hand Repair Cream Broad Spectrum SPF 18]


name: Benzoyl Peroxide;Benzoyl Peroxide;Gel, Multi Ingredient 2.5%; 5%; NA Multiple Routes Kit


name: Biotin/Cholecalciferol/Copper/Cyanocobalamin/Folic Acid/Heme Iron Polypeptide/Iodine/Iron Polysaccharide/Niacin/Pantothenic Acid/Pyridoxine/Riboflavin/Selenium/Thiamine/Vitamin E/Zinc;Docosahexaenoic Acid/Docosapentaenoic Acid/Linolenic Acid 30 MCG-400 IU-0.8 MG-12 MCG-1 MG-6 MG-250 MCG-28 MG-17 MG-10 MG-50 MG-1.6 MG-65 MCG-1.5 MG-10 IU-4.5 MG; 200 MG-2.5 MG-0.5 MG Oral Kit


name: Bupivacaine Hydrochloride;Isopropyl Alcohol;Lidocaine Hydrochloride;Povidone Iodine 0.25%; 70%; 1%; 10% Multiple Routes Kit [ACTIVE INJECTION KIT LM-2]


name: Bupivacaine Hydrochloride;Povidone Iodine;Triamcinolone Acetonide 0.5%; 10%; 40 MG/1 ML Multiple Routes Kit [ACTIVE INJECTION KIT KM]


name: Capsaicin/Menthol/Methyl Salicylate;Gabapentin 0.0375%-5%-20%; 300 MG Multiple Routes Kit


name: Dexamethasone Sodium Phosphate;Isopropyl Alcohol;Lidocaine Hydrochloride;Povidone Iodine 10 MG/1 ML; 70%; 1%; 10% Multiple Routes Kit [ACTIVE INJECTION KIT DL]


name: Dexamethasone Sodium Phosphate;Isopropyl Alcohol;Povidone Iodine 10 MG/1 ML; 70%; 10% Multiple Routes Kit [ACTIVE INJECTION KIT D]


name: Diclofenac Sodium;Isopropyl Alcohol 1.5%; 70% Topical application Kit


name: Gabapentin;Lidocaine 600 MG; 5% Multiple Routes Kit


name: Isopropyl Alcohol;Lidocaine Hydrochloride;Methylprednisolone Acetate 70%; 1%; 40 MG/1 ML Multiple Routes Kit [ACTIVE INJECTION KIT L]


name: Lidocaine/Prilocaine;Povidone Iodine;Sodium Chloride 2.5%-2.5%; 1%; 0.9% Multiple Routes Kit


name: Venetoclax;Venetoclax;Venetoclax 10 MG; 50 MG; 100 MG Oral Tablet


name: Cleanser Topical application Solution [VANICREAM GENTLE FACIAL CLEANSER]


name: Gabapentin;Lidocaine 600 MG; 5% Multiple Routes Kit [CONVENIENCE PAK]


name: Ammonia/Ethanol;Lidocaine Hydrochloride;Povidone Iodine;Triamcinolone Acetonide 15%-35%; 1%; 10%; 40 MG/1 ML Multiple Routes Kit [ACTIVE INJECTION KIT KL-3]


name: {60 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 8]


name: {30 (lenvatinib 10 MG Oral Capsule) / 60 (lenvatinib 4 MG Oral Capsule) } Pack


name: AVOBENZONE 0.9 g in 100 g / OCTOCRYLENE 2 g in 100 g / OXYBENZONE 1.5 g in 100 g TOPICAL LOTION [Meijer SPF 8]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 13 g in 100 g / OCTOCRYLENE 2 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [ULTA FACE SPF 30]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 5.5 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g TOPICAL LOTION [Meijer Sheer Moisturing SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 11.7 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4.5 g in 100 g / OXYBENZONE 5.4 g in 100 g TOPICAL LOTION [Meijer Sport SPF 50]


name: OCTINOXATE 60 mg in 1 mL / ZINC OXIDE 50 mg in 1 mL TOPICAL CREAM [Tropical Vanilla Sunscreen Broad Spectrum SPF 32]


name: TITANIUM DIOXIDE 5.3 g in 100 g / ZINC OXIDE 7 g in 100 g TOPICAL CREAM [BB Broad Spectrum SPF 15 Light]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [Premium Natural Sunscreen Broad Spectrum SPF 30 Baby Bum]


name: aluminum phosphate / dimethicone / magnesium hydroxide


name: CSF in left side of metencephalon part of fourth ventricle


name: Portion of renal filtrate in loop of Henle


name: Portion of urine in collecting duct of renal tubule


name: Portion of renal filtrate in proximal convoluted tubule


name: Portion of renal filtrate in distal convoluted tubule


name: Portion of renal filtrate in descending limb of loop of Henle


name: Portion of renal filtrate in ascending limb of loop of Henle


name: Portion of urine in collecting duct of renal tubule in right kidney


name: Portion of urine in collecting duct of renal tubule in left kidney


name: CSF in right side of medulla part of fourth ventricle


name: CSF in left side of medulla part of fourth ventricle


name: CSF in right side of metencephalon part of fourth ventricle


name: Send document that conforms to C-CDA R1.1 template


name: Send document that conforms to C-CDA R1.1 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to C-CDA R2.0 template


name: Send document that conforms to C-CDA R2.0 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to C-CDA R2.1 template


name: Send document that conforms to C-CDA R2.1 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to CDP Set 1 R1.0 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to CDP Set 1 R1.0 template


name: Send document that conforms to CDP Set 1 R1.1 template


name: Send document that conforms to CDP Set 1 R1.1 template:Scope.modifier.doc template:Pt:X12^277:-


name: Setting of exposure to illness:Type:Pt:^Patient:Nom


name: Public health laboratory ask at order entry panel


name: Public health laboratory ask at order entry panel:-:-:^Patient:-


name: Pulmonary function test panel:-:Pt:Respiratory system:-


name: Referring physician phone number:Tele:Pt:Provider:Nom


name: {90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Mili 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Mili 28 Day]


name: Other genomic reference sequence coding system OID:URI:Pt:^Patient:Nom


name: Other transcript reference sequence coding system OID:URI:Pt:^Patient:Nom


name: Structural variant ISCN name:Find:Pt:^Patient:Nom


name: Trimester at onset of illness:Time:Pt:^Patient:Ord


name: Daytime Nighttime Sinus Relief Maximum Strength KIT


name: Source used for population RMR:Type:Pt:Reference source:Nom


name: Source used for predicted RMR:Type:Pt:Reference source:Nom


name: Source used for reported activity metabolic rate


name: Source used for reported activity metabolic rate:Type:Pt:Reference source:Nom


name: Source used to adjust activity MET:Type:Pt:Reference source:Nom


name: Source used to estimate activity metabolic rate


name: Source used to estimate activity metabolic rate:Type:Pt:Reference source:Nom


name: State or province of birth:Loc:Pt:^Patient:Nom


name: Post-discharge provider practice address


name: Transfer summary note - recommended C-CDA R2.0 sections


name: PROMIS short form - cognitive function 8a - version 2.0


name: Preoperative measures for patient safety panel


name: Fractional flow reserve performed:Find:Pt:^Patient:Ord


name: Frequency of bone-strengthening physical activity:NRat:RptPeriod:^Patient:Qn


name: Frequency of bone-strengthening physical activity


name: Frequency of moderate to vigorous aerobic physical activity:NRat:RptPeriod:^Patient:Qn


name: Frequency of muscle-strengthening physical activity:NRat:RptPeriod:^Patient:Qn


name: Frequency of muscle-strengthening physical activity


name: Deprecated t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method


name: Tissue perfusion assessment panel:-:Pt:^Patient:-


name: allogeneic hematopoietic stem cell transplant


name: Complex variant HGVS name:Find:Pt:^Patient:Nom


name: Sample variant allelic frequency:NFr:Pt:^Patient:Qn


name: Enhanced discharge summary - recommended CDP Set 1 R1.0 sections:-:Pt:{Setting}:-


name: Document template attachment request modifier codes:-:Pt:X12^277:-


name: Composite triage and nursing note - recommended IHE set:-:Pt:^Patient:-


name: GDAP1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Genomic structural variant copy number:Num:Pt:^Patient:Qn


name: Genomic structural variant name:Find:Pt:^Patient:Nom


name: Transfer summary note - recommended C-CDA R2.0 sections:-:Pt:{Setting}:-


name: Transfer summary note - recommended C-CDA R2.1 sections:-:Pt:{Setting}:-


name: Transfer summary note - recommended C-CDA R2.1 sections


name: Composite triage and nursing note - recommended IHE set


name: {1 (acetaminophen 21.7 MG/ML / dextromethorphan hydrobromide 0.667 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) / 1 (acetaminophen 21.7 MG/ML / diphenhydramine hydrochloride 0.833 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) } Pack


name: Evaluation and management of workers compensation form


name: Document template attachment request modifier codes


name: Nutrition and fluid intake assessment panel


name: Catalogue of Somatic Mutations in Cancer (COSMIC)


name: Post-discharge provider practice phone number:Tele:Pt:Provider:Nom


name: Post-discharge provider practice address:Addr:Pt:Provider:Nom


name: Post-discharge provider practice name:ID:Pt:Provider:Nom


name: Post-discharge provider practice ID:ID:Pt:Provider:Nom


name: Cardiogenic shock within 24H prior to procedure:Hx:24H:^Patient:Ord


name: Cardiac arrest within 24H prior to procedure:Hx:24H:^Patient:Ord


name: Coronary stent end coordinates:Type:Pt:Coronary arteries:Nom


name: Coronary stent end segment:Type:Pt:Coronary arteries:Nom


name: Coronary stent end segment position:Type:Pt:Coronary arteries:Nom


name: PROMIS short form - cognitive function 4a - version 2.0


name: Varicella zoster virus surveillance panel:-:Pt:^Patient:-


name: Varicella zoster virus surveillance panel


name: Verified availability of correct implants and any special equipment or requirements:Find:Pt:^Patient:Ord


name: Verified two types of patient identification:Find:Pt:^Patient:Ord


name: Discharge summary - recommended C-CDA R2.0 sections:-:Pt:{Setting}:-


name: Discharge summary - recommended C-CDA R2.1 sections:-:Pt:{Setting}:-


name: Evaluation and management of workers compensation form:Find:Pt:{Setting}:Doc:{Role}


name: Evaluation and management of workers compensation note:Find:Pt:{Setting}:Doc:{Role}


name: Intra-aortic balloon pump used:Find:Pt:^Patient:Ord


name: Date and time of surgery:TmStp:Pt:^Patient:Qn


name: Coronary stent start coordinates:Type:Pt:Coronary arteries:Nom


name: Coronary stent start segment:Type:Pt:Coronary arteries:Nom


name: Coronary stent number:Number:Duration of the procedure:Heart:Quantitative


name: Coronary stent start segment position:Type:Pt:Coronary arteries:Nom


name: Post-discharge provider practice telephone number


name: Evaluation and management of workers compensation note


name: Discharge summary - recommended C-CDA R2.1 sections


name: Other genomic reference sequence coding system OID


name: PROMIS item bank - cognitive function - version 2.0


name: Personal advance care plan R1.0 - recommended CDA sections


name: National health care surveys report R1 - recommended CDA set


name: Meeting recommended guidelines for physical activity


name: LOINC Document Ontology associated observations panel


name: PROMIS short form - cognitive function 6a - version 2.0


name: Enhanced discharge summary - recommended CDP Set 1 R1.1 sections


name: Percutaneous coronary intervention performed:Find:Pt:Heart:Ord


name: CYP1A2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CYP2C9 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: LOINC Document Ontology associated observations panel:-:Pt:Clinical document:-


name: Master HL7 genetic variant reporting panel:-:Pt:^Patient:-


name: (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) Ab.IgE:ACnc:Pt:Ser:Qn


name: Master HL7 genetic variant reporting panel


name: Enhanced discharge summary - recommended CDP Set 1 R1.0 sections


name: Other transcript reference sequence coding system OID


name: PROMIS short form - cognitive function - abilities subset 4a - version 2.0


name: PROMIS short form - cognitive function - abilities subset 6a - version 2.0


name: Medical equipment or product list:Find:Pt:{Setting}:Doc:{Role}


name: Medication usage implications panel:-:Pt:^Patient:-


name: Meeting recommended guidelines for physical activity:Find:Pt:^Patient:Ord


name: Method used to measure RMR:Type:Pt:^Patient:Nom


name: National health care surveys report R1 - recommended CDA set:-:Pt:^Patient:-


name: Discharge summary - recommended C-CDA R2.0 sections


name: Notary commission expiration date:Date:Pt:^Witness:Nom


name: Nutrition and fluid intake assessment panel:-:Pt:^Patient:-


name: Absolute aerobic exercise intensity:Type:Pt:^Patient:Ord


name: Percutaneous coronary intervention site:Anat:Pt:*:Nom


name: Performed preoperative time-out assessment:Find:Pt:^Patient:Ord


name: Personal advance care plan R1.0 - recommended CDA sections:-:Pt:{Setting}:-


name: Physical activity guideline used:Type:Pt:Reference source:Nom


name: Physical activity panel:-:Reporting period:^Patient:-


name: Enhanced discharge summary - recommended CDP Set 1 R1.1 sections:-:Pt:{Setting}:-


name: Preoperative measures for patient safety panel:-:Pt:^Patient:-


name: Preoperative verification process panel:-:Pt:^Patient:-


name: PRNP gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Safety issue assessment note:Find:Pt:{Setting}:Doc:{Role}


name: PROMIS cognitive function - abilities subset - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS cognitive function - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS item bank - cognitive function - abilities subset - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS item bank - cognitive function - abilities subset - version 2.0


name: PROMIS item bank - cognitive function - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 4a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function - abilities subset 6a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function - abilities subset 8a - version 2.0


name: PROMIS short form - cognitive function - abilities subset 8a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function 4a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function 6a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function 8a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: laboratory processing of microbial specimen to include culture and sensitivity studies, preparation and transmission of written report


name: non-ionizing diagnostic procedure capable of quantifying, monitoring, and recording changes in structure of enamel, dentin, and cementum


name: scaling in presence of generalized moderate or severe gingival inflammation - full mouth, after oral evaluation


name: scaling and debridement in the presence of inflammation or mucositis of a single implant, including cleaning of the implant surfaces, without flap entry and closure


name: consultation with a medical health care professional


name: dental case management - addressing appointment compliance barriers


name: dental case management - care coordination


name: dental case management - motivational interviewing


name: dental case management - patient education to improve oral health literacy


name: distal shoe space maintainer - fixed, unilateral - per quadrant


name: Aurora Unifine Pentips Plus 31G 5/16 inch Short Pen Needle


name: Aurora Unifine Pentips Plus 31G 3/16 inch Mini Pen Needle


name: Aurora Unifine Pentips Plus 31G 1/4 inch Ultra Short Pen Needle


name: Anti-Static Compact Space Chamber Plus with Mask (Small)


name: Anti-Static Compact Space Chamber Plus with Mask (Medium)


name: Anti-Static Compact Space Chamber Plus with Mask (Large)


name: Aurora Unifine Pentips Plus 32G 5/32 inch Micro Pen Needle


name: My MDI Portable Nebulizer Procedure Pack


name: Fluocinolone Acetonide;Urea 0.01%; 20% Topical application Kit [NOXIPAK KIT]


name: CVS Severe Daytime/Nighttime Multi-Symptom Cold/Flu Relief Twin Pack


name: CVS Cold Relief Daytime/Nighttime Multi-Symptom Cool Blast Caplet


name: CVS Lip Treatment Petroleum Jelly Lip Balm


name: BD Safety-Lok Blood Collection Set, 23g 3/4"


name: Unifine Pentips Plus Pen Needles 32g 4mm


name: Unifine Pentips Plus Pen Needles 31g 8mm


name: Unifine Pentips Plus Pen Needles 31g 5mm


name: Monoject Insulin Syringe 0.5cc 30g 5/16"


name: BD Syringe Safety Luer-Lok 1 cc 25g 5/8"


name: Silver 1.2% Topical application Dressing [AQUACEL AG FOAM DRESSING]


name: Camphor/Menthol/Methyl Salicylate;Diclofenac Sodium 3.1%-6%-10%; 1.5% Multiple Routes Kit [INFLAMMA-K]


name: Fluocinolone Acetonide;Urea 0.01%; 20% Topical application Kit


name: Dimethicone;Lidocaine 5%; 5% Multiple Routes Kit


name: Camphor/Menthol;Sumatriptan Succinate 4%-10%; 50 MG Multiple Routes Kit


name: Camphor/Menthol/Methyl Salicylate;Diclofenac Sodium 3.1%-6%-10%; 1.5% Multiple Routes Kit


name: Dimethicone 0.09 g in 9 g TOPICAL STICK [PANDAS DREAM SO COOL EYE SERUM]


name: OCTINOXATE 3.5 mg in 50 mL / OCTOCRYLENE 2.5 mg in 50 mL / OCTISALATE 2 mg in 50 mL TOPICAL GEL [Lagom Cellus Sun Gel]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Femynor 28 Day]


name: Glycerin 4.0 g in 200 mL TOPICAL CREAM [2X FIRST ESSENCE]


name: Glycerin 3.0 g in 50 g / Niacinamide 1.0 g in 50 g TOPICAL CREAM [PANDAS DREAM MAGIC]


name: AVOBENZONE 3 g in 75 mL / OCTINOXATE 7.5 g in 75 mL / OCTISALATE 4 g in 75 mL / OXYBENZONE 2 g in 75 mL TOPICAL CREAM [Day Care for Hands Broad Spectrum SPF 15 Jafra]


name: Titanium Dioxide 1.86 g in 45 mL / Octinoxate 1.80 g in 45 mL / Zinc Oxide 1.29 g in 45 mL TOPICAL CREAM [MY SUNNY POWDE RY FINISH SUN MILK]


name: Octinoxate 2.75 g in 50 mL / Octisalate 2.50 g in 50 mL / ENSULIZOLE 2.00 g in 50 mL / AVOBENZONE 1.50 g in 50 mL TOPICAL CREAM [TIMELESS FERMENT SANIL SUN]


name: GLYCERIN 13 mg in 1 mL TOPICAL LIQUID [3 en 1 Cleanser. Deep Cleansing]


name: DIMETHICONE 1.52 mg in 1 mL TOPICAL LIQUID [Cleanser Dermopurifying Oily Skin]


name: DIMETHICONE 0.95 mg in 1 mL / GLYCERIN 6.125 mg in 1 mL TOPICAL LIQUID [Cleanser Sensitive Skin]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 45 mg in 1 mL TOPICAL CREAM [Tinted Radiance Moisturizer Broad Spectrum SPF 32]


name: Octinoxate 0.075 g in 1 g / Oxybenzone 0.02 g in 1 g / Zinc Oxide 0.0196 g in 1 g TOPICAL SUSPENSION [LBEL CLARITE Clarifying Effect Foundation SPF 30 CLAIRE 1- BEIGE]


name: DIMETHICONE 0.01 g in 100 mL TOPICAL CREAM [ARGAN AIR WATER BANG ESSENCE]


name: Lidocaine/Prilocaine;Triamcinolone Acetonide 2.5%-2.5%; 40 MG/1 ML Multiple Routes Kit [DERMACINRX CINLONE-I CPI]


name: DIMETHICONE 0.76 mg in 1 mL / GLYCERIN 5.35 mg in 1 mL TOPICAL LIQUID [Cleanser Balancing]


name: OCTINOXATE 6.9 g in 100 mL / OCTISALATE 3 g in 100 mL / ZINC OXIDE 4 g in 100 mL TOPICAL CREAM [BOTANICAL SOOTHING SPF-30]


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Larissia 28 Day Pack]


name: {1 (dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML Oral Solution) } Pack


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 13 g in 100 g / OCTOCRYLENE 1 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [Walgreens Sport Faces SPF 30]


name: GLYCERIN 0.25 g in 5 mL TOPICAL SOLUTION [ZNSP Ampoule]


name: GLYCERIN 0.16 g in 8 g TOPICAL CREAM [ZNSP Repair]


name: TITANIUM DIOXIDE 3.2 g in 100 g / ZINC OXIDE 4 g in 100 g TOPICAL LOTION [Meijer Kids Tear Free SPF 50]


name: GREEN TEA LEAF 44.71 g in 55 mL TOPICAL CREAM [The Chok Chok Green Tea Watery Essence]


name: Glycerin 9.3 g in 60 mL / Niacinamide 1.2 g in 60 mL TOPICAL CREAM [NATURALTH GOAT MILK PREMIUM TONE UP]


name: Glycerin 9 g in 150 mL TOPICAL EMULSION [NATURALTH GOAT MILK MOISTURE]


name: Glycerin 0.15 g in 150 mL TOPICAL LIQUID [NATURALTH GOAT MILK MOISTURE TONER]


name: Dimethicone 0.3 g in 75 mL TOPICAL CREAM [MIZON ALL IN ONE SNAIL REPAIR]


name: OCTINOXATE 6 g in 100 mL / ZINC OXIDE 3 g in 100 mL TOPICAL CREAM [Covergirl cgsmoothers BB Tinted Moisturizer Broad Spectrum SPF 21 (all shades)]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 8 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [Meijer Sheer SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL LOTION [Rite Aid SPF 50]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 13 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 2 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [Meijer Oil Free Faces SPF 30]


name: AVOBENZONE 1.8 g in 100 g / HOMOSALATE 7 g in 100 g / OCTOCRYLENE 5 g in 100 g TOPICAL LOTION [Rite Aid SPF 30]


name: ZINC OXIDE 7 g in 100 g / TITANIUM DIOXIDE 4.7 g in 100 g TOPICAL CREAM [BB Broad Spectrum SPF 15 Medium]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [Kypris Pot of Shade Heliotropic Broad Spectrum SPF 30 Sunscreen And Primer]


name: TITANIUM DIOXIDE 57.8 mg in 1 mL / ZINC OXIDE 37.4 mg in 1 mL TOPICAL CREAM [Island Remedy All-day Revitalizing Moisturizer with SPF 30]


name: TITANIUM DIOXIDE 4.7 g in 100 g / ZINC OXIDE 7 g in 100 g TOPICAL CREAM [BB Broad Spectrum SPF 15 Light to Medium]


name: TITANIUM DIOXIDE 3.2 g in 100 g / ZINC OXIDE 4 g in 100 g TOPICAL LOTION [Meijer Baby Tear Free SPF 50]


name: OXYBENZONE 60 mg in 1 mL / AVOBENZONE 15 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 13 mg in 1 mL TOPICAL LOTION [Defense Zone Sport Broad Spectrum SPF 50 Sunscreen]


name: Ascorbic Acid/Potassium/Sodium;Polyethylene Glycol 3350 50%-75 MG/1.5 GM-70 MG/1.5 GM; 17 GM/1 DOSE Oral Powder for Solution [GIALAX]


name: sumatriptan succinate/menthol/camphor 50 mg-10 %-4 % MISCELL KIT, GEL AND TABLET


name: lidocaine/dimethicone 5 %-5 % TOPICAL KIT, PATCH, MEDICATED AND CREAM


name: fluocinolone acetonide/urea/silicone, adhesive 0.01 %-20 % TOPICAL KIT


name: doxycycline monohydrate 100 % MISCELL POWDER (GRAM)


name: diclofenac sodium/methyl salicylate/menthol/camphor 1.5 %-10 %-6 %-3.1 % TOPICAL KIT, PATCH, MEDICATED AND SOLUTION DROPS


name: catheter male,external 22 mm to 25 mm MISCELL EACH


name: cardioplegic solution no.18 (induction 8:1) 70 mEq/300 mL (potassium) PERFUSION PLASTIC BAG, PERFUSION (ML)


name: {60 (lenvatinib 4 MG Oral Capsule) } Pack


name: KIT, PATCH, MEDICATED AND SOLUTION DROPS


name: balanced salt irrigation soln combo no.4


name: cardioplegic solution no.17 (induction 4:1)


name: enteral pump accessory for fat hydrolysis


name: camphor / Eucalyptus oil / levomenthol / peppermint oil / thymol


name: influenza A virus A/California/7/2009 (H1N1) antigen / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen


name: TRACH TUBE,SZ 10 SINGLE CANNULA SHLY 10SCT


name: POUCH,DRAINABLE,CENTER POINT LOCK H#8817


name: CATHETER,INTERMITTENT,MAGIC3 12FR ROCHESTER #50612


name: CATHETER,INTERMITTENT COUDE 14FR PECO #PU614C


name: CATHERIZATION SET,INTERMITTENT 12FR VAPRO PLUS H#74124


name: BRIEF,BREATHABLE EXTRA ABSORBENT X-SMALL ATTENDS


name: BANDAGE,ELASTIC MATRIX 4IN X 5YD,LF,STERILE


name: BANDAGE,ELASTIC MATRIX 3IN X 5YD,LF,STERILE


name: Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2


name: Introduction of Inactivated Coagulation Factor Xa into Central Vein, Percutaneous Approach, New Technology Group 2


name: Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein, Percutaneous Approach, New Technology Group 2


name: Reposition of Thoracic Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2


name: Reposition of Cervical Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2


name: Reposition of Lumbar Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2


name: Cerebral Embolic Filtration, Dual Filter in Innominate Artery and Left Common Carotid Artery, Percutaneous Approach, New Technology Group 2


name: Perfusion of Urinary System Donor Organ, Single


name: Perfusion of Hepatobiliary System and Pancreas Donor Organ, Single


name: Perfusion of Respiratory System Donor Organ, Single


name: Perfusion of Circulatory Donor Organ, Single


name: Monitoring of Skin and Breast Vascular Perfusion using Indocyanine Green Dye, External Approach


name: Monitoring of Gastrointestinal Vascular Perfusion using Indocyanine Green Dye, External Approach


name: Monitoring of Cardiac Vascular Perfusion using Indocyanine Green Dye, External Approach


name: Introduction of Destructive Agent into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Gas into Cranial Cavity and Brain, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Radioactive Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Anesthetic Agent into Cranial Cavity and Brain, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Nutritional Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Anti-inflammatory into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach


name: Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Open Approach


name: Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Percutaneous Approach


name: Transplantation of Left Hand, Syngeneic, Open Approach


name: Transplantation of Left Hand, Allogeneic, Open Approach


name: Transplantation of Right Hand, Syngeneic, Open Approach


name: Transplantation of Right Hand, Allogeneic, Open Approach


name: Transplantation of Face, Syngeneic, Open Approach


name: Transplantation of Face, Allogeneic, Open Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, External Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, Open Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, External Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, Open Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, External Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, Open Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, External Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, Open Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, External Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, Open Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, External Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, Open Approach


name: Replacement of Left Knee Joint with Medial Unicondylar Synthetic Substitute, Open Approach


name: Replacement of Left Knee Joint with Medial Unicondylar Synthetic Substitute, Uncemented, Open Approach


name: Replacement of Left Knee Joint with Medial Unicondylar Synthetic Substitute, Cemented, Open Approach


name: Replacement of Right Knee Joint with Medial Unicondylar Synthetic Substitute, Open Approach


name: Replacement of Right Knee Joint with Medial Unicondylar Synthetic Substitute, Uncemented, Open Approach


name: Replacement of Right Knee Joint with Medial Unicondylar Synthetic Substitute, Cemented, Open Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Tibial Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Tibial Surface, Open Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Tibial Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Tibial Surface, Open Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Acetabular Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Acetabular Surface, Open Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Patellar Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Patellar Surface, Open Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Patellar Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Patellar Surface, Open Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Acetabular Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Acetabular Surface, Open Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, External Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, Percutaneous Endoscopic Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, Percutaneous Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, Open Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, External Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, Percutaneous Endoscopic Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, Percutaneous Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, Open Approach


name: Revision of Neurostimulator Lead in Azygos Vein, External Approach


name: Revision of Monitoring Device in Azygos Vein, External Approach


name: Revision of Neurostimulator Lead in Azygos Vein, Percutaneous Endoscopic Approach


name: Revision of Monitoring Device in Azygos Vein, Percutaneous Endoscopic Approach


name: Revision of Neurostimulator Lead in Azygos Vein, Percutaneous Approach


name: Revision of Monitoring Device in Azygos Vein, Percutaneous Approach


name: Revision of Neurostimulator Lead in Azygos Vein, Open Approach


name: Revision of Monitoring Device in Azygos Vein, Open Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, External Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, Percutaneous Endoscopic Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, Percutaneous Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, Open Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, External Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, Percutaneous Endoscopic Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, Percutaneous Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, Open Approach


name: Removal of Neurostimulator Lead from Azygos Vein, External Approach


name: Removal of Monitoring Device from Azygos Vein, External Approach


name: Removal of Neurostimulator Lead from Azygos Vein, Percutaneous Endoscopic Approach


name: Removal of Monitoring Device from Azygos Vein, Percutaneous Endoscopic Approach


name: Removal of Neurostimulator Lead from Azygos Vein, Percutaneous Approach


name: Removal of Monitoring Device from Azygos Vein, Percutaneous Approach


name: Removal of Neurostimulator Lead from Azygos Vein, Open Approach


name: Removal of Monitoring Device from Azygos Vein, Open Approach


name: Insertion of Neurostimulator Lead into Left Innominate Vein, Percutaneous Endoscopic Approach


name: Insertion of Neurostimulator Lead into Left Innominate Vein, Percutaneous Approach


name: Insertion of Neurostimulator Lead into Left Innominate Vein, Open Approach


name: Insertion of Neurostimulator Lead into Right Innominate Vein, Percutaneous Endoscopic Approach


name: Insertion of Neurostimulator Lead into Right Innominate Vein, Percutaneous Approach


name: Insertion of Neurostimulator Lead into Right Innominate Vein, Open Approach


name: Insertion of Neurostimulator Lead into Azygos Vein, Percutaneous Endoscopic Approach


name: Insertion of Monitoring Device into Azygos Vein, Percutaneous Endoscopic Approach


name: Insertion of Neurostimulator Lead into Azygos Vein, Percutaneous Approach


name: Insertion of Monitoring Device into Azygos Vein, Percutaneous Approach


name: Insertion of Neurostimulator Lead into Azygos Vein, Open Approach


name: Insertion of Monitoring Device into Azygos Vein, Open Approach


name: Restriction of Left Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Endoscopic Approach


name: Restriction of Left Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach


name: Restriction of Left Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Open Approach


name: Restriction of Right Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Endoscopic Approach


name: Restriction of Right Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach


name: Restriction of Right Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Open Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, Three or More Arteries, Percutaneous Endoscopic Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Endoscopic Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, Three or More Arteries, Percutaneous Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, Three or More Arteries, Open Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Open Approach


name: Dilation of Lower Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Approach